Position in RXST
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$656,890
-$290,517 QoQ
Shares Held
106,638
+17.3% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026ExodusPoint Capital Management, LP holds $345,630,527 across 29 Medical Devices names. RXST ranks #23 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
465,215 | $152,762,649 | |
| 2 | LIVN |
LivaNova PLC
|
495,618 | $31,501,480 | |
| 3 | DXCM |
Dexcom Inc
|
317,067 | $19,911,807 | |
| 4 | BSX |
Boston Scientific Corp
|
311,363 | $19,538,028 | |
| 5 | GKOS |
GLAUKOS Corp
|
179,728 | $19,349,516 | |
| 6 | GMED |
Globus Medical Inc
|
208,902 | $17,998,996 | |
| 7 | EW |
Edwards Lifesciences Corp
|
215,124 | $17,227,129 | |
| 8 | TNDM |
Tandem Diabetes Care Inc
|
632,899 | $12,132,673 |
All Filings in RXST
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $656,890 | 106,638 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $947,407 | 90,922 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $606,123 | 67,422 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $402,586 | 15,944 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $839,456 | 24,417 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $883,956 | 17,883 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $573,260 | 11,114 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||